Cargando…

Extensive CFTR Gene Analysis Revealed a Higher Occurrence of Cystic Fibrosis Transmembrane Regulator-Related Disorders (CFTR-RD) among CF Carriers

Background: A wide range of cystic fibrosis (CF)-related conditions are reported in CF carriers, but no study has explored the possibility that such subjects may be affected by cystic fibrosis transmembrane regulator-related disorders (CFTR-RD). No data are available so far on the occurrence of CFTR...

Descripción completa

Detalles Bibliográficos
Autores principales:	Esposito, Maria Valeria, Aveta, Achille, Comegna, Marika, Cernera, Gustavo, Iacotucci, Paola, Carnovale, Vincenzo, Taccetti, Giovanni, Terlizzi, Vito, Castaldo, Giuseppe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7760778/ https://www.ncbi.nlm.nih.gov/pubmed/33260873 http://dx.doi.org/10.3390/jcm9123853

Ejemplares similares

Impaired Ratio of Unsaturated to Saturated Non-Esterified Fatty Acids in Saliva from Patients with Cystic Fibrosis
por: Gelzo, Monica, et al.
Publicado: (2020)

S737F is a new CFTR mutation typical of patients originally from the Tuscany region in Italy
por: Terlizzi, Vito, et al.
Publicado: (2018)

Ex vivo model predicted in vivo efficacy of CFTR modulator therapy in a child with rare genotype
por: Terlizzi, Vito, et al.
Publicado: (2021)

Clinical Consequences and Functional Impact of the Rare S737F CFTR Variant and Its Responsiveness to CFTR Modulators
por: Terlizzi, Vito, et al.
Publicado: (2023)

G378X‐I148T CFTR variant: A new complex allele in a cystic fibrosis newborn with pancreatic insufficiency
por: Terlizzi, Vito, et al.
Publicado: (2022)

CF Fungal Disease in the Age of CFTR Modulators
por: Bercusson, Amelia, et al.
Publicado: (2021)

TAS2R38 is a novel modifier gene in patients with cystic fibrosis
por: Castaldo, Alice, et al.
Publicado: (2020)

New therapies for people with CF in the CFTR modulator world
por: Wainwright, Claire E
Publicado: (2020)

CRMS/CFSPID Subjects Carrying D1152H CFTR Variant: Can the Second Variant Be a Predictor of Disease Development?
por: Terlizzi, Vito, et al.
Publicado: (2020)

The cystic fibrosis transmembrane conductance regulator (CFTR) and its stability
por: Meng, Xin, et al.
Publicado: (2016)

Transmembrane helical interactions in the CFTR channel pore
por: Das, Jhuma, et al.
Publicado: (2017)

Salivary Cytokines and Airways Disease Severity in Patients with Cystic Fibrosis
por: Castaldo, Alice, et al.
Publicado: (2020)

Comparative effects of CFTR modulators on phagocytic, metabolic and inflammatory profiles of CF and nonCF macrophages
por: Aridgides, Daniel S., et al.
Publicado: (2023)

Elexacaftor–Tezacaftor–Ivacaftor Therapy for Cystic Fibrosis Patients with The F508del/Unknown Genotype
por: Comegna, Marika, et al.
Publicado: (2021)

Sweat rate analysis of ivacaftor potentiation of CFTR in non-CF adults
por: Kim, Jeeyeon, et al.
Publicado: (2018)

Fertility, Pregnancy and Lactation Considerations for Women with CF in the CFTR Modulator Era
por: Jain, Raksha, et al.
Publicado: (2021)

CFTR mutations altering CFTR fragmentation
por: Tosoni, Kendra, et al.
Publicado: (2012)

Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Potentiators Protect G551D but Not ΔF508 CFTR from Thermal Instability
por: Liu, Xuehong, et al.
Publicado: (2014)

Optimizing Nasal Potential Difference Analysis for CFTR Modulator Development: Assessment of Ivacaftor in CF Subjects with the G551D-CFTR Mutation
por: Rowe, Steven M., et al.
Publicado: (2013)

Alteration of CFTR transmembrane span integration by disease-causing mutations
por: Patrick, Anna E., et al.
Publicado: (2011)

Structure of Transmembrane Helix 8 and Possible Membrane Defects in CFTR
por: Corradi, Valentina, et al.
Publicado: (2018)

State of the Art on Approved Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Modulators and Triple-Combination Therapy
por: Meoli, Aniello, et al.
Publicado: (2021)

Relating the Disease Mutation Spectrum to the Evolution of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR)
por: Rishishwar, Lavanya, et al.
Publicado: (2012)

The cystic fibrosis transmembrane recruiter the alter ego of CFTR as a multi-kinase anchor
por: Mehta, Anil
Publicado: (2007)

'CFTR-opathies': disease phenotypes associated with cystic fibrosis transmembrane regulator gene mutations
por: Noone, Peadar G, et al.
Publicado: (2001)

Cystic Fibrosis Transmembrane Conductance Regulator (CFTR): CLOSED AND OPEN STATE CHANNEL MODELS
por: Corradi, Valentina, et al.
Publicado: (2015)

Multicenter Intestinal Current Measurements in Rectal Biopsies from CF and Non-CF Subjects to Monitor CFTR Function
por: Clancy, John P., et al.
Publicado: (2013)

Restoration of CFTR function in patients with cystic fibrosis carrying the F508del-CFTR mutation
por: Stefano, Daniela De, et al.
Publicado: (2014)

Phenotypes of CF rabbits generated by CRISPR/Cas9-mediated disruption of the CFTR gene
por: Xu, Jie, et al.
Publicado: (2021)

A survey: Understanding the health and perspectives of people with CF not benefiting from CFTR modulators
por: Kramer‐Golinkoff, Emily, et al.
Publicado: (2022)

Locating the Anion-selectivity Filter of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Chloride Channel
por: Cheung, Min, et al.
Publicado: (1997)

Expression of ΔF508 Cystic Fibrosis Transmembrane Regulator (CFTR) Decreases Membrane Sialylation
por: Dosanjh, Amrita, et al.
Publicado: (2009)

The Mechanistic Links between Insulin and Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Cl(−) Channel
por: Marunaka, Yoshinori
Publicado: (2017)

Signaling Cascade Involved in Rapid Stimulation of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) by Dexamethasone
por: Bossmann, Miriam, et al.
Publicado: (2017)

Cholesterol Interaction Directly Enhances Intrinsic Activity of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR)
por: Chin, Stephanie, et al.
Publicado: (2019)

Lower Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Promotes the Proliferation and Migration of Endometrial Carcinoma
por: Xia, Xian, et al.
Publicado: (2017)

Bacterial Sphingomyelinase is a State-Dependent Inhibitor of the Cystic Fibrosis Transmembrane conductance Regulator (CFTR)
por: Stauffer, B. B., et al.
Publicado: (2017)

Geographic distribution of cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations in Saudi Arabia
por: Banjar, Hanaa, et al.
Publicado: (2021)

A Review of Trikafta: Triple Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Modulator Therapy
por: Zaher, Anas, et al.
Publicado: (2021)

Molecular dynamics study of Cl(−) permeation through cystic fibrosis transmembrane conductance regulator (CFTR)
por: Zeng, Zhi Wei, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_bm7ng6i3mbq2nvr4g7gk1nokpk